As of Feb 22
| -0.58 / -0.43%|
The 20 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 148.50, with a high estimate of 174.00 and a low estimate of 106.00. The median estimate represents a +11.09% increase from the last price of 133.67.
The current consensus among 23 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.